CompletedPhase 2/3

Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations

United States150 participantsStarted 2024-10-12

Plain-language summary

The primary purpose of this study is to compare the safety and effectiveness of commercially available dietary supplements believed to increase coenzyme Q10 (CoQ10) concentrations. An 8-week, randomized, placebo-controlled clinical trial will be conducted comparing the effectiveness of four commercially available dietary supplements on increasing CoQ10 concentrations and self-reported health outcomes.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult males or females age ≥ 40 years
✓. Ability to read and speak English

Exclusion criteria

✕. Daily use within the past 2 months of any dietary supplements containing CoQ10 or geranylgeraniol (GG)
✕. Taking a statin medication within the past 6 months
✕. Current daily usage of H2 blockers or PPI medications
✕. Current daily use of bisphosphonates
✕. Current daily tobacco smoker
✕. Known allergies to any substance in the study products
✕. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks
✕. Current diagnosis of a chronic health condition (e.g., cancer, Crohn's disease) deemed clinically contraindicated for the study protocol.

What they're measuring

Plasma Coenzyme Q10

Timeframe: Baseline and 8 weeks

Trial details

NCT IDNCT06640465

SponsorOvationLab

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2025-09-17

View on ClinicalTrials.gov More Wellness trials